Biologics and Biosimilars -Promising field for medicines for the future by Dr. Dhananjay Patankar (Head-Pharmaceutical and Biopharmaceutical Development)
Pharma Focus Asia-09/03/2017. As per Make in India campaign by the government, Indian biotech industry, comprising bio pharmaceuticals, is expected to grow at a rate of 30 per cent a year and reach US$100 billion by 2025.
Syngene to co-develop nutrition products for Herbalife
Business Standard-02/03/2017. It is Syngene's fifth dedicated facility and second for nutrition research, the lab is a testimony of its capabilities to deliver innovative solutions in wide industry segments.
Herbalife teams up with Syngene to develop, formulate nutrition products
The Hindu Businessline-02/03/2017. The new nutrition R&D facility will be housed within the Syngene campus, with around 10 Syngene scientists working on Herbalife formulations.